
|Articles|October 1, 2002
In the pipeline: B&L, InSite to develop compound for infections
San Dimas, CA-Bausch & Lomb and InSite Vision will develop a fourth-generation fluoroquinolone that incorporates InSite Vision's drug delivery system, DuraSite.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
2
New optoretinography technique allows direct measurement of rod function in vivo
3
FDA grants breakthrough therapy designation to Oculis’ privosegtor for optic neuritis
4
Long-lived Greenland sharks may point to new approaches for retinal disease
5












































